BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36729773)

  • 21. Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study.
    Selma-Royo M; Bäuerl C; Mena-Tudela D; Aguilar-Camprubí L; Pérez-Cano FJ; Parra-Llorca A; Lerin C; Martínez-Costa C; Collado MC
    Genome Med; 2022 Apr; 14(1):42. PubMed ID: 35449030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Difference in levels of SARS-CoV-2 S1 and S2 subunits- and nucleocapsid protein-reactive SIgM/IgM, IgG and SIgA/IgA antibodies in human milk.
    Demers-Mathieu V; Do DM; Mathijssen GB; Sela DA; Seppo A; Järvinen KM; Medo E
    J Perinatol; 2021 Apr; 41(4):850-859. PubMed ID: 32873904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection.
    Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Briker SM; Triebwasser JE; Gerber JS; Morris JS; Weirick ME; McAllister CM; Hensley SE; Puopolo KM
    JAMA Netw Open; 2022 Nov; 5(11):e2240993. PubMed ID: 36350652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralizing Antibodies and Cytokines in Breast Milk After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination.
    Narayanaswamy V; Pentecost BT; Schoen CN; Alfandari D; Schneider SS; Baker R; Arcaro KF
    Obstet Gynecol; 2022 Feb; 139(2):181-191. PubMed ID: 35104067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-SARS-CoV-2 antibodies in breast milk during lactation after infection or vaccination: A cohort study.
    Olearo F; Radmanesh LS; Felber N; von Possel R; Emmerich P; Pekarek N; Pfefferle S; Nörz D; Hansen G; Diemert A; Aepfelbacher M; Hecher K; Lütgehetmann M; Arck PC; Tallarek AC
    J Reprod Immunol; 2022 Sep; 153():103685. PubMed ID: 36029724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective functional antibody transfer into the breastmilk after SARS-CoV-2 infection.
    Pullen KM; Atyeo C; Collier AY; Gray KJ; Belfort MB; Lauffenburger DA; Edlow AG; Alter G
    Cell Rep; 2021 Nov; 37(6):109959. PubMed ID: 34739850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants.
    Longueira Y; Ojeda DS; Battistelli RBA; Sanchez L; Oviedo Rouco S; Albano D; Guevara E; Valls V; Pando MA; Gamarnik AV
    Front Immunol; 2022; 13():909995. PubMed ID: 36263055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies.
    Rick AM; Lentscher A; Xu L; Wilkins MS; Nasser A; Tuttle DJ; Megli C; Marques ETA; McElroy AK; Williams JV; Martin JM
    PLoS One; 2023; 18(6):e0287103. PubMed ID: 37310982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
    Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies Against SARS-CoV-2 in Human Milk: Milk Conversion Rates in the Netherlands.
    Juncker HG; Romijn M; Loth VN; Ruhé EJM; Bakker S; Kleinendorst S; de Groot CJM; Pajkrt D; Korosi A; van Goudoever JB; van Gils MJ; van Keulen BJ
    J Hum Lact; 2021 Aug; 37(3):469-476. PubMed ID: 33982613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of IgA and IgG Antibodies against the Structural Proteins of SARS-CoV-2 in Breast Milk and Serum Samples Derived from Breastfeeding Mothers.
    Cortés-Sarabia K; Guzman-Silva V; Martinez-Pacheco KM; Meza-Hernández JA; Luna-Pineda VM; Leyva-Vázquez MA; Vences-Velázquez A; Beltrán-Anaya FO; Del Moral-Hernández O; Illades-Aguiar B
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112946
    [No Abstract]   [Full Text] [Related]  

  • 32. Maternal Antibody Response, Neutralizing Potency, and Placental Antibody Transfer After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Joseph NT; Dude CM; Verkerke HP; Irby LS; Dunlop AL; Patel RM; Easley KA; Smith AK; Stowell SR; Jamieson DJ; Velu V; Badell ML
    Obstet Gynecol; 2021 Aug; 138(2):189-197. PubMed ID: 33910220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Milk From Women Diagnosed With COVID-19 Does Not Contain SARS-CoV-2 RNA but Has Persistent Levels of SARS-CoV-2-Specific IgA Antibodies.
    Pace RM; Williams JE; Järvinen KM; Meehan CL; Martin MA; Ley SH; Barbosa-Leiker C; Andres A; Yeruva L; Belfort MB; Caffé B; Navarrete AD; Lackey KA; Pace CDW; Gogel AC; Fehrenkamp BD; Klein M; Young BE; Rosen-Carole C; Diaz N; Gaw SL; Flaherman V; McGuire MA; McGuire MK; Seppo AE
    Front Immunol; 2021; 12():801797. PubMed ID: 35003130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of neonatal SARS-CoV-2 anti-spike protein receptor-binding domain antibodies at delivery with infant SARS-CoV-2 infection under the age of 6 months: a prospective cohort study.
    Oz-Alcalay L; Elron E; Davidovich R; Chodick G; Osovsky M; Chen R; Ashkenazi-Hoffnung L
    Clin Microbiol Infect; 2023 Jun; 29(6):789-794. PubMed ID: 36739973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Cross-sectional and Longitudinal HLA and Anti-viral Responses After COVID Infection in Renal Allograft Recipients: Differences and Correlates.
    Girnita AL; Wang L; Colovai AI; Ahearn P; Azzi Y; Menon MC; Fernandez-Vina M; Gebel HM; Steve Woodle E; Cravedi P; Maltzman JS; Akalin E
    Transplantation; 2022 Oct; 106(10):2085-2091. PubMed ID: 36070571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination.
    Stafford LS; Valcarce V; Henry M; Neu J; Parker L; Mueller M; Vicuna V; Gowen T; Cato E; Kosik I; Yewdell JW; Atkinson M; Cacho N; Li N; Larkin J
    J Perinatol; 2023 Jun; 43(6):775-781. PubMed ID: 36631564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal-Fetal Immunologic Response to SARS-CoV-2 Infection in a Symptomatic Vulnerable Population: A Prospective Cohort.
    Larcade R; DeShea L; Lang GA; Caballero MT; Ferretti A; Beasley WH; Tipple TE; Vain N; Prudent L; Lang ML; Polack FP; Ofman G
    J Infect Dis; 2022 Mar; 225(5):800-809. PubMed ID: 34865064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal Antibody Response and Transplacental Transfer Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection or Vaccination in Pregnancy.
    Otero S; Miller ES; Sunderraj A; Shanes ED; Sakowicz A; Goldstein JA; Mithal LB
    Clin Infect Dis; 2023 Jan; 76(2):220-228. PubMed ID: 36348510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy.
    Kugelman N; Nahshon C; Shaked-Mishan P; Cohen N; Sher ML; Gruber M; Marom I; Zolotarevsky A; Lavie O; Damti A; Zilberlicht A; Bardicef M; Kedar R
    JAMA Pediatr; 2022 Mar; 176(3):290-295. PubMed ID: 34932066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.
    Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.